Highly selective HPK1 inhibitor NDI-101150 mediates immune cell activation and robust antitumor responses, distinct from immune checkpoint blockadeDavid Ciccone, Christine Loh, Scott Boiko et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 8